BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 16234965)

  • 1. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.
    Sornay-Rendu E; Boutroy S; Munoz F; Delmas PD
    J Bone Miner Res; 2007 Mar; 22(3):425-33. PubMed ID: 17181395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and bone loss measured at the radius to predict the risk of nonspinal osteoporotic fracture.
    Gnudi S; Malavolta N; Lisi L; Ripamonti C
    J Bone Miner Res; 2001 Jun; 16(6):1130-5. PubMed ID: 11393790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between osteoporosis and cardiovascular disease in postmenopausal women.
    Tankó LB; Christiansen C; Cox DA; Geiger MJ; McNabb MA; Cummings SR
    J Bone Miner Res; 2005 Nov; 20(11):1912-20. PubMed ID: 16234963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disc space narrowing as a new risk factor for vertebral fracture: the OFELY study.
    Sornay-Rendu E; Allard C; Munoz F; Duboeuf F; Delmas PD
    Arthritis Rheum; 2006 Apr; 54(4):1262-9. PubMed ID: 16572461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
    Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
    J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
    Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
    Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study.
    Garnero P; Sornay-Rendu E; Duboeuf F; Delmas PD
    J Bone Miner Res; 1999 Sep; 14(9):1614-21. PubMed ID: 10469291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between back pain and future vertebral fracture in postmenopausal women.
    Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T
    Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.